Multidisciplinary Care Driving Metastatic Colorectal Cancer Treatment

EP: 1.Epidemiology of Metastatic Colorectal Cancer

EP: 2.Financial Impact Associated With Colorectal Cancer Care

EP: 3.Importance of Early Detection For Patients With mCRC

EP: 4.Emotional and Physical Challenges Affecting Caregivers and Patients Diagnosed With mCRC

Now Viewing

EP: 5.Multidisciplinary Care Driving Metastatic Colorectal Cancer Treatment

EP: 6.Targetable Mutations Investigated Or Utilized in mCRC

EP: 7.Implementing Targeted Therapies Into mCRC Treatment Algorithm

EP: 8.First-, and Second-, and Third-Line Agents in mCRC

EP: 9.mCRC Treatment Sequencing Influenced By Combination Therapy

EP: 10.Advancements in Colorectal Cancer Research

EP: 11.Evaluating Precision Medicine in mCRC

EP: 12.Emerging Technologies and Diagnostic Tools For Early Detection of mCRC

Ben George, MD, and David Fenstermacher, PhD, emphasize the importance of multidisciplinary care in the treatment of colorectal cancer and the vital role played by various health care professionals.

Ryan Haumschild, PharmD, MS, MBA, highlights the significance of the multidisciplinary care team and discusses the collaboration between medical oncologists, surgical oncologists, pathologists, and other specialists. Dr George emphasizes the teamwork required in treating metastatic colorectal cancer (mCRC) and mentions the importance of bringing various experts together to discuss patient cases during tumor board meetings and conferences. He acknowledges the contribution of health care professionals who work behind the scenes, such as nurses, pharmacists, palliative care doctors, and radiologists, in providing comprehensive care.

The discussion underscores the essential role of these health care professionals in delivering seamless and patient-centric care. Dr George also emphasizes the importance of adherence to treatment plans, in which the nurses, palliative care doctors, and pharmacists play a significant role in ensuring that patients follow their therapies, translating clinical trial results into real-world outcomes.

The conversation pivots to the critical role of patient and family education in improving patient outcomes. Dr Fenstermacher highlights the Colorectal Cancer Alliance’s program, Cycles of Impact, which focuses on educating underserved populations in the Philadelphia area about the importance of screening. He emphasizes the need for educating patients about the various screening options available, including colonoscopy, fecal immunochemical tests, and Cologuard.

Dr Fenstermacher discusses the challenges patients face in navigating their cancer journey, from understanding treatment options and clinical trials to deciphering complex guidelines. He emphasizes the role of advocacy groups and patient navigators in helping patients through their journey with colorectal cancer.

Dr Fenstermacher introduces a self-help tool called Blue Q, designed to empower patients by providing tailored resources based on their cancer type, stage, and biomarkers. This tool helps patients have informed conversations with their health care providers about their diagnosis, treatment options, and clinical trials.

The experts stress that patient education is vital for empowering individuals to take control of their cancer treatment. Empowered patients are more likely to have productive discussions with their health care providers, leading to improved outcomes. Education is not limited to patients alone but extends to caregivers, who also need support and resources to navigate the complexities of colorectal cancer care.

Video synopsis is AI-generated and reviewed by AJMC editorial staff.